The FDA has approved pirtobrutinib (Jaypirca) treatment for adults with relapsed/refractory chronic lymphocytic leukemia or ...
The covid-19 pandemic opened the door to once-controversial human challenge trials. Now, volunteers are willingly catching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback